176 related articles for article (PubMed ID: 9740229)
1. Oxidative activity of the type 2 isozyme of 17beta-hydroxysteroid dehydrogenase (17beta-HSD) predominates in human sebaceous glands.
Thiboutot D; Martin P; Volikos L; Gilliland K
J Invest Dermatol; 1998 Sep; 111(3):390-5. PubMed ID: 9740229
[TBL] [Abstract][Full Text] [Related]
2. Structure, function and tissue-specific gene expression of 3β-hydroxysteroid dehydrogenase/5-ene-4-ene isomerase enzymes in classical and peripheral intracrine steroidogenic tissues.
Labrie F; Simard J; Luu-The V; Bélanger A; Pelletier G
J Steroid Biochem Mol Biol; 1992 Dec; 43(8):805-26. PubMed ID: 22217825
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of 17 beta-hydroxysteroid dehydrogenases.
Poirier D
Curr Med Chem; 2003 Mar; 10(6):453-77. PubMed ID: 12570693
[TBL] [Abstract][Full Text] [Related]
4. Regulation of sex steroid formation by interleukin-4 and interleukin-6 in breast cancer cells.
Turgeon C; Gingras S; Carrière MC; Blais Y; Labrie F; Simard J
J Steroid Biochem Mol Biol; 1998 Apr; 65(1-6):151-62. PubMed ID: 9699868
[TBL] [Abstract][Full Text] [Related]
5. Androgen metabolism in sebaceous glands from subjects with and without acne.
Thiboutot D; Gilliland K; Light J; Lookingbill D
Arch Dermatol; 1999 Sep; 135(9):1041-5. PubMed ID: 10490108
[TBL] [Abstract][Full Text] [Related]
6. Characterization and modulation of sex steroid metabolizing activity in normal human keratinocytes in primary culture and HaCaT cells.
Gingras S; Turgeon C; Brochu N; Soucy P; Labrie F; Simard J
J Steroid Biochem Mol Biol; 2003 Nov; 87(2-3):167-79. PubMed ID: 14672737
[TBL] [Abstract][Full Text] [Related]
7. Activity of the type 1 5 alpha-reductase exhibits regional differences in isolated sebaceous glands and whole skin.
Thiboutot D; Harris G; Iles V; Cimis G; Gilliland K; Hagari S
J Invest Dermatol; 1995 Aug; 105(2):209-14. PubMed ID: 7636302
[TBL] [Abstract][Full Text] [Related]
8. 17Beta-hydroxysteroid dehydrogenases in human bone cells.
Dong Y; Qiu QQ; Debear J; Lathrop WF; Bertolini DR; Tamburini PP
J Bone Miner Res; 1998 Oct; 13(10):1539-46. PubMed ID: 9783542
[TBL] [Abstract][Full Text] [Related]
9. Loss of estrogen inactivation in colonic cancer.
English MA; Kane KF; Cruickshank N; Langman MJ; Stewart PM; Hewison M
J Clin Endocrinol Metab; 1999 Jun; 84(6):2080-5. PubMed ID: 10372714
[TBL] [Abstract][Full Text] [Related]
10. Analysis and characteristics of multiple types of human 17beta-hydroxysteroid dehydrogenase.
Luu-The V
J Steroid Biochem Mol Biol; 2001; 76(1-5):143-51. PubMed ID: 11384872
[TBL] [Abstract][Full Text] [Related]
11. Androgen formation and metabolism in the pulmonary epithelial cell line A549: expression of 17beta-hydroxysteroid dehydrogenase type 5 and 3alpha-hydroxysteroid dehydrogenase type 3.
Provost PR; Blomquist CH; Godin C; Huang XF; Flamand N; Luu-The V; Nadeau D; Tremblay Y
Endocrinology; 2000 Aug; 141(8):2786-94. PubMed ID: 10919264
[TBL] [Abstract][Full Text] [Related]
12. Selective insensitivity of ZR-75-1 human breast cancer cells to 2-methoxyestradiol: evidence for type II 17beta-hydroxysteroid dehydrogenase as the underlying cause.
Liu ZJ; Lee WJ; Zhu BT
Cancer Res; 2005 Jul; 65(13):5802-11. PubMed ID: 15994956
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of estrogenic 17beta-hydroxysteroid dehydrogenase (17beta-HSD) activity in the human brain.
Steckelbroeck S; Watzka M; Reissinger A; Wegener-Toper P; Bidlingmaier F; Bliesener N; Hans VH; Clusmann H; Ludwig M; Siekmann L; Klingmüller D
J Steroid Biochem Mol Biol; 2003 Jul; 86(1):79-92. PubMed ID: 12943747
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of type II 17beta-hydroxysteroid dehydrogenase.
Poirier D; Bydal P; Tremblay MR; Sam KM; Luu-The V
Mol Cell Endocrinol; 2001 Jan; 171(1-2):119-28. PubMed ID: 11165020
[TBL] [Abstract][Full Text] [Related]
15. Type 5 17beta-hydroxysteroid dehydrogenase: its role in the formation of androgens in women.
Luu-The V; Dufort I; Pelletier G; Labrie F
Mol Cell Endocrinol; 2001 Jan; 171(1-2):77-82. PubMed ID: 11165014
[TBL] [Abstract][Full Text] [Related]
16. Activity of 5-alpha-reductase and 17-beta-hydroxysteroid dehydrogenase in the infrainfundibulum of subjects with and without acne vulgaris.
Thiboutot D; Knaggs H; Gilliland K; Lin G
Dermatology; 1998; 196(1):38-42. PubMed ID: 9557222
[TBL] [Abstract][Full Text] [Related]
17. 17beta-Hydroxysteroid dehydrogenase type 9 and other short-chain dehydrogenases/reductases that catalyze retinoid, 17beta- and 3alpha-hydroxysteroid metabolism.
Napoli JL
Mol Cell Endocrinol; 2001 Jan; 171(1-2):103-9. PubMed ID: 11165018
[TBL] [Abstract][Full Text] [Related]
18. Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men.
Blouin K; Richard C; Brochu G; Hould FS; Lebel S; Marceau S; Biron S; Luu-The V; Tchernof A
J Endocrinol; 2006 Dec; 191(3):637-49. PubMed ID: 17170221
[TBL] [Abstract][Full Text] [Related]
19. Androgen metabolism via 17beta-hydroxysteroid dehydrogenase type 3 in mammalian and non-mammalian vertebrates: comparison of the human and the zebrafish enzyme.
Mindnich R; Haller F; Halbach F; Moeller G; Hrabé de Angelis M; Adamski J
J Mol Endocrinol; 2005 Oct; 35(2):305-16. PubMed ID: 16216911
[TBL] [Abstract][Full Text] [Related]
20. Evolution of 17beta-hydroxysteroid dehydrogenases and their role in androgen, estrogen and retinoid action.
Baker ME
Mol Cell Endocrinol; 2001 Jan; 171(1-2):211-5. PubMed ID: 11165032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
